The global atrial fibrillation market is expected to reach USD 16.17
billion by 2020. Rising occurrence of strokes, brain damage and atrial
fibrillation owing to blood clots along with an increasing geriatric population
is expected to drive industry growth. Technological advancements in the field
of microwave catheter ablation and radiofrequency along with rising occurrence
of diseases caused by lifestyle habits such as drinking and smoking are further
expected to fuel growth. Moreover, increasing demand for smaller cardiac
incisions, minimally invasive procedures and small recovery time post-surgery
are projected to bolster growth. Also, global aging population combined with
the changes in lifestyle increasing the risks of obesity and high blood
pressure is likely to drive demand.
Pharmacological products
accounted for over 50% market share in 2013. Low prices of these products along
with increasing use of anti-coagulants as an add-on therapy to
non-pharmacological procedures are expected to drive demand.
Access Research Report of Atrial fibrillation market@ www.grandviewresearch.com/industry-analysis/atrial-fibrillation-treatment-industry
North America accounted
for over 40% of global revenue in 2013. High penetration of non-pharmacological
procedure and sophisticated reimbursement frameworks has resulted in its
substantial demand over the past few years. High patient awareness and
healthcare expenditure levels also contributed significantly towards region
growth.
Asia-Pacific is expected
to witness substantial growth during the forecast period, growing at a CAGR of
over 13% from 2015 to 2022. Rising demand for non-pharmacological treatments
due to improvement in healthcare infrastructure, high disposable incomes, and
growing patient awareness are a few factors accounting for its rapid growth.
Radiofrequency catheter
ablation procedure segment is expected to be the fastest growing segment with a
CAGR of over 12% over the forecast period. Technological advancements related
to maneuverability which helps in making tight bends inside the heart, the
optimal size of the lesion produced and lower time required to recover from of
catheter ablation is expected to drive demand over the next seven years.
Maze surgery occupied
the second largest share of non-pharmacological treatment market. It removes
the need for life-long anti-coagulants based treatment while reducing the
occurrence of strokes. Anti-coagulants held the dominant market share in
pharmacological treatment market as it reduced the incidence of blood clots and
strokes which in turn is likely to propel demand over the projected period.
Key industry players
include Boston Scientific Corporation, St. Jude Medical Inc., Johnson &
Johnson Ltd., Sanofi-Aventis, CardioFocus Inc., Boehringer Ingelheim GmbH,
Bristol-Myers Squibb Corporation, Biosense Webster Inc., AtriCure Inc. and
Endoscopic Technologies Inc. St. Jude Medical Inc. developed an
Endosense’sTactiCath. The technology provides live feedback related to pressure
applied during microwave catheter ablations and radiofrequency.
Grand View Research has
segmented the global atrial fibrillation market on the basis of fields of
procedures and region:
Atrial Fibrillation Procedures Outlook
·
Pharmacological Products
o
Anti-arrhythmic Drugs
o
Anti-coagulant Drugs
·
Non-Pharmacological Treatment
o
Catheter Ablation Procedures
o
Radiofrequency
o
HIFU
o
Cryoablation
o
Microwave
o
Laser
o
Maze Surgery
o
Electric Cardioversion
Atrial Fibrillation Regional Outlook
·
North America
·
Europe
·
Asia Pacific
·
RoW
Access Press Release of Atrial fibrillation market@ www.grandviewresearch.com/press-release/global-atrial-fibrillation-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business decisions,
we offer market intelligence studies ensuring relevant and fact-based research
across a range of industries, from technology to chemicals, materials and
healthcare.
No comments:
Post a Comment